Artificial Intelligence in Drug Discovery

A podcast by Simon Smith

Categories:

Technology

12 Episodes

  1. Nick Lynch of the Pistoia Alliance on AI as a Strategic Focus

    Published: 8/7/2018

  2. Lucas Siow of ProteinQure on AI for Protein-Based Drugs

    Published: 8/7/2018

  3. Regina Barzilay, AI Small Molecule Discovery and Synthesis

    Published: 7/30/2018

  4. Tim Guilliams and David Brown, Healx, AI for Rare Diseases

    Published: 7/26/2018

  5. John Cassidy, CEO, Cambridge Cancer Genomics, AI in Oncology

    Published: 7/18/2018

  6. Kristen Fortney, CEO of BioAge Labs, on AI Aging Research

    Published: 7/10/2018

  7. Sam Cooper, CEO of Phenomic AI, on Automated HCS and More

    Published: 6/28/2018

  8. Shai Shen-Orr, Chief Scientist, CytoReason, AI in Immunology

    Published: 6/20/2018

  9. Leila Pirhaji, CEO of ReviveMed, on AI for Metabolomics

    Published: 6/11/2018

  10. Mostapha Benhenda of Startcrowd on AI Drug Discovery Hype

    Published: 5/29/2018

  11. Mauro Cozzi, Researchably, AI for Better Biomedical Search

    Published: 5/22/2018

  12. Dekel Gelbman, CEO of FDNA, on "Next-Generation Phenotyping"

    Published: 5/14/2018

1 / 1

Get knowledge and inspiration to apply artificial intelligence to drug development. Discover startups applying machine learning to biomedical research. Hear how biotech and pharma companies use AI to speed discovery and cut costs. Learn from academic researchers pushing boundaries in applying computation to biology. We interview leaders transforming drug development with data and algorithms. Subscribe now and never miss an episode!